GBM44 GBM Model
GBM44, a Patient-Derived Xenograft (PDX) model, provides a window into the world of brain cancer. Explore its characteristics to uncover new treatment strategies and mechanisms. PDX models like GBM44 are indispensable for preclinical drug discovery because they replicate the patient’s tumor heterogeneity. Researchers can use GBM44 to screen and prioritize drug candidates, increasing the likelihood of successful clinical translation. By leveraging GBM44, you contribute to the development of targeted therapies and better outcomes for brain cancer patients.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM44
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GBM44 Survival
Survival of orthotopic intracranial implanted GBM44 in Nu/Nu mice (n=5)
